The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain

John W. McDonald, William H. Trescher, Michael V. Johnston

Research output: Contribution to journalArticlepeer-review

Abstract

Direct unilateral intrastriatal stereotaxic injections of the selective ionotropic-type quisqualate receptor agonist, AMPA, in postnatal day 7 rats produced tonic-clonic seizure activity. Quantitative analysis of the severity of brain injury was assessed by comparison of the disparities in the weights of injected and contralateral cerebral hemispheres 3 days after the excitotoxin injection. The amount of AMPA that produced half-maximal brain injury was 9.5 nmol as assessed by comparison of disparities in cerebral hemisphere weights. In contrast, quisqualate was 26 times less potent. The marked susceptibility of the developing rat brain to AMPA toxicity may provide a useful model to assess the neuroprotective effectiveness and selectivity of ionotropic quisqualate receptor antagonists.

Original languageEnglish (US)
Pages (from-to)165-168
Number of pages4
JournalBrain research
Volume526
Issue number1
DOIs
StatePublished - Aug 27 1990

Keywords

  • Development
  • Excitatory amino acid
  • Excitotoxicity
  • Glutamate
  • Neurotoxicity
  • Quisqualate
  • Rat
  • α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain'. Together they form a unique fingerprint.

Cite this